Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep25 | Adrenal and Cardiovascular Endocrinology | ECE2023

Endocannabinoids in patients with adrenal incidentalomas. A new prognostic biomarker?

Mytareli Chrysoula , Athanasouli Fani , Karampela Athina , Papalexis Petros , Siampanopoulou Vasiliki , Lafioniatis Alexandros , Mantzourani Marina , Angelousi Anna

Background: The majority of adrenal incidentalomas (AIs) are benign non-functioning adrenocortical adenomas (NFAIs), yet not clinically silent. Possible autonomous cortisol secretion (PACS) can also be diagnosed in up to 50% of patients. Endocannabinoids (ECs) have recently been studied regarding their role in the hypothalamo-pituitary-adrenocortical (HPA) axis; however, data are scarce in humans.Aim: We aimed to assess hair EC [anandamide (AEA) and 2-ar...

ea0073oc14.4 | Oral Communications 14: Across Endocrinology | ECE2021

Evaluation of the hypothalamic-pituitary-adrenal axis suppression in kidney transplant recipients and its association with metabolic parameters

Angelousi Anna , Tsiakas Stathis , Xagas Efstathios , Athanasouli Fani , Marinaki Smaragdi , Boletis Ioannis

IntroductionCorticosteroids are included in the maintenance immunosuppressive regimen in most kidney transplant recipients. Studies evaluating the effect of chronic low-dose glucocorticoid treatment on the hypothalamic-pituitary-adrenal (HPA) axis and the metabolic profile of these patients are limited.AimThe objective of the study was to evaluate the metabolic effects and the alterations of HPA axis regulati...

ea0073aep49 | Adrenal and Cardiovascular Endocrinology | ECE2021

Hair cortisol levels in patients with adrenal incidentalomas compared to healthy controls

Athanasouli Fani , Mytareli Chrysoula , Andreadaki Evangelia , Petychaki Foteini , Savelli Akrivi , Asonitis Nikos , Anna Angelousi

BackgroundAdrenal incidentalomas (AI) are present in 3–10% of the general population. Up to 20% of them may have autonomous cortisol secretion (ACS). However, subclinical hypercortisolism isn’t clearly defined. The 1mg dexamethasone suppression test (ODST) is the most widely accepted for the screening of these patients. Recent data suggest that hair cortisol should be considered as a routine test for the screening of Cushing syndrome.<p cla...

ea0073pep3.6 | Presented ePosters 3: Pituitary and Neuroendocrinology | ECE2021

Comparative study of growth hormone stimulation levels in growth hormone deficient children vs children with idiopathic short stature

Sofia Leka-Emiri , Athanasouli Fani , Tampouratzi Dimitra , Kafetzi Maria , Dikaiakou Eirini , Petrou Vasilios , Vlachopapadopoulou Elpis , Michalakos Stefanos

IntroductionShort stature (SS) assessment includes the documentation of growth hormone (GH) secretion via GH stimulation tests.ObjectivesTo study retrospectively GH stimulation test results among Greek children with SS and investigate differences among GH deficient (GHD) children vs idiopathic short stature (ISS).MethodsData were collected retrospectively from 190...